The patients with GPRC5A and IMUP genes altered (all types of alteration besides amplification) showed worse overall, disease free and progression free survival than patients without gene alterations, indicating the genes’ potential value in cancer development (data not shown). The gene discussed is GPRC5A; the disease is cancer.